Á. Muñoz-Fernández

发表

Water-soluble carbosilane dendrimers: synthesis biocompatibility and complexation with oligonucleotides; evaluation for medical applications.

R. Eritja, J. F. Bermejo, P. Ortega, 2007, Chemistry.

Virological Response after Short-Term CCR5 Antagonist Exposure in HIV-Infected Patients: Frequency of Subjects with Virological Response and Associated Factors

E. Ruiz-Mateos, M. Leal, Á. Muñoz-Fernández, 2011, Antimicrobial Agents and Chemotherapy.

Outside-binding site mutations modify the active site's shapes in neuraminidase from influenza A H1N1.

J. Correa-Basurto, L. Tolentino-López, I. Ilizaliturri-Flores, 2013, Biopolymers.

Neuroprotective effects of early antiretrovirals in vertical HIV infection.

S. Sánchez-Ramón, Á. Muñoz-Fernández, S. Resino, 2003, Pediatric neurology.

Interleukin (IL)-1β, IL-6 and IL-8 in nasal secretions: a common role for innate immunity in viral bronchial infection in infants?

Á. Muñoz-Fernández, D. Bernardo, J. A. Garrote, 2006, British journal of biomedical science.

Effects of highly active antiretroviral therapy on thymical reconstitution of CD4 T lymphocytes in vertically HIV-infected children.

Á. Muñoz-Fernández, R. Corrêa, 2002, AIDS.

Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.

Á. Muñoz-Fernández, D. Micheloud, S. Resino, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Predictive Markers of Clinical Outcome in Vertically HIV-1–Infected Infants. A Prospective Longitudinal Study

S. Sánchez-Ramón, Á. Muñoz-Fernández, S. Resino, 2000, Pediatric Research.

TITLE : EFFECTS OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY WITH NELFINAVIR IN VERTICALLY HIV-1 INFECTED CHILDREN : 3 YEARS OF FOLLOW-UP RUNNING TITLE : LONG-TERM RESPONSE TO NELFINAVIR IN CHILDREN

Á. Muñoz-Fernández, M. Navarro, S. Resino, 2006 .

Stopping antiretroviral therapy in 'prematurely treated' HIV-1-infected children with full viral supression is safe.

M. Leal, Á. Muñoz-Fernández, I. Obando, 2006, AIDS.

Eosinophilic appendicitis due to Strongyloides stercoralis: a challenging differential diagnosis for clinicians

Á. Muñoz-Fernández, J. Páramo-Zunzunegui, Laura Rubio-López, 2021, BMJ Case Reports.

Pentoxifylline and severe acute respiratory syndrome (SARS): a drug to be considered.

Á. Muñoz-Fernández, J. Jiménez, Jesús Fco Bermejo Martin, 2003, Medical science monitor : international medical journal of experimental and clinical research.

Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug users

J. Benito, Á. Muñoz-Fernández, J. Carbone, 2000, AIDS.

Combined use of honey, bee propolis and myrrh in healing a deep, infected wound in a patient with diabetes mellitus

M. Shigematsu, Á. Muñoz-Fernández, T. Sekizuka, 2006, British journal of biomedical science.

CYP27B1 rs10877012 T allele was linked to non-AIDS progression in ART-naïve HIV-infected patients: a retrospective study.

Á. Muñoz-Fernández, S. Resino, J. Bellón, 2020, Journal of acquired immune deficiency syndromes.

W HIV-1 infection and in the current era

S. Álvarez, Á. Muñoz-Fernández, M. Muñoz-Fernandez, 2011 .